SANUWAVE Health, Inc. - Common Stock (SNWV)

Sanuwave Health (NASDAQ:SNWV) reported second-quarter 2026 revenue of $9.7 million, down 3% from $10.1 million a year earlier, as lower UltraMIST system sales offset continued growth in the company’s recurring applicator business. Chairman and Chief Executive Officer Morgan Frank said applicator sa

NASDAQ:SNWV shares are trading down 0.5% in premarket as SANUWAVE Health beats Q2 revenue expectations, but faces financial constraints and competition.

Sanuwave (SNWV) Q4 2025 Earnings Transcript

Sanuwave (SNWV) Q1 2026 Earnings Transcript

Sanuwave Health (NASDAQ:SNWV) reported record first-quarter revenue and rising consumables utilization, while management said the advanced wound care market began to recover after a difficult start to the year tied to changes in reimbursement for skin substitutes. Chairman and CEO Morgan Frank said

U.S. stock futures fell on Tuesday following Monday’s mixed moves. Futures of major benchmark indices were lower.

U.S. stock futures mixed, key stocks to watch: MKC, SNWV, PENG, TELO, SAR. Check out premarket coverage. Cramer warns on chip stock.

These are three healthcare stocks offering a compelling combination of secure business, strong fundamentals, and growth opportunity.